Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form.

Neil MehtaJennifer L DodgeJohn P RobertsRyutaro HiroseFrancis Y Yao

Published in: Clinical transplantation (2017)

The rate of misdiagnosis was 11% among T2 HCC patients who underwent LT without receiving LRT prior to LT and did not change significantly after implementation of LI-RADS. More efforts are needed to eliminate unnecessary LT for patients without HCC.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
primary care
stem cells
quality improvement
patient reported outcomes
replacement therapy